Cost-Effectiveness Of The SQ® Grass SLIT-Tablet In Children With Allergic Rhinitis: A German Payer Perspective.
Christian VogelbergEckard HamelmannUlrich WahnAnne DomdeyRichard F PollockTobias Sydendal GrandPublished in: ClinicoEconomics and outcomes research : CEOR (2019)
Improvements in quality of life with the SQ grass SLIT-tablet would be accompanied by only a modest increase in costs over a 10-year time horizon, with the SQ grass SLIT-tablet therefore representing excellent value for money from the German healthcare payer perspective.
Keyphrases